晚期癌症呼吸困难的治疗:ASCO指南

2021-02-22 美国临床肿瘤学会

2月22日,JCO在线发布ASCO指南,为成人晚期癌症患者呼吸困难的临床治疗提供指导。

中文标题:

晚期癌症呼吸困难的治疗:ASCO指南

英文标题:

Management of Dyspnea in Advanced Cancer: ASCO Guideline

发布机构:

美国临床肿瘤学会

发布日期:

2021-02-22

简要介绍:

2月22日,JCO在线发布ASCO指南,为成人晚期癌症患者呼吸困难的临床治疗提供指导。

指南建议采用分层的方法来管理呼吸困难,首先对呼吸困难进行评估,确定和管理潜在的可逆原因,然后转诊到跨学科的姑息治疗小组。指南显示,可用于缓解呼吸困难的非药物干预措施包括气流干预(例如,将风扇对脸吹),低氧血症患者的标准吸氧治疗以及其他心理教育、自我管理或补充方法。对于那些从非药物干预中得不到充分缓解的患者,应该提供全身性阿片类药物。指南还讨论了其他药理学干预措施,如皮质类固醇和苯二氮卓类药物。

Management of Dyspnea in Advanced Cancer ASCO Guideline.pdf

评论区 (20)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1051769, encodeId=ec3e1051e692f, content=值得学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c905475903, createdName=湘雅科教, createdTime=Thu Sep 16 00:16:30 CST 2021, time=2021-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007288, encodeId=fb65100e28816, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210813/759caf56c3484eacbfe31dd805343725/ef96d9acb98241bcbae5f1d696677e20.jpg, createdBy=2d545571357, createdName=ms4000000843810017, createdTime=Thu Aug 12 15:01:59 CST 2021, time=2021-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=973439, encodeId=0ce99e343951, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210615/49ed71c9ebbe4efab84b5b13e4ffdc4d/f76222ffae3944948a4c06e684458801.jpg, createdBy=89155326955, createdName=148bedacm12暂无昵称, createdTime=Mon Jun 14 13:06:31 CST 2021, time=2021-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=971820, encodeId=feb39e182008, content=学习啦, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5c8e5452710, createdName=ms4000001114161496, createdTime=Tue Jun 08 13:04:39 CST 2021, time=2021-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970921, encodeId=a9bd9e092125, content=学习了٩(๑^o^๑)۶, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210604/089492f938c14d9388763519ccaa8830/9e41eaeb5362468d9c0ced660e8eda2a.jpg, createdBy=65941381866, createdName=happycooler, createdTime=Fri Jun 04 16:57:01 CST 2021, time=2021-06-04, status=1, ipAttribution=)]
    2021-09-16 湘雅科教

    值得学习

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1051769, encodeId=ec3e1051e692f, content=值得学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c905475903, createdName=湘雅科教, createdTime=Thu Sep 16 00:16:30 CST 2021, time=2021-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007288, encodeId=fb65100e28816, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210813/759caf56c3484eacbfe31dd805343725/ef96d9acb98241bcbae5f1d696677e20.jpg, createdBy=2d545571357, createdName=ms4000000843810017, createdTime=Thu Aug 12 15:01:59 CST 2021, time=2021-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=973439, encodeId=0ce99e343951, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210615/49ed71c9ebbe4efab84b5b13e4ffdc4d/f76222ffae3944948a4c06e684458801.jpg, createdBy=89155326955, createdName=148bedacm12暂无昵称, createdTime=Mon Jun 14 13:06:31 CST 2021, time=2021-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=971820, encodeId=feb39e182008, content=学习啦, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5c8e5452710, createdName=ms4000001114161496, createdTime=Tue Jun 08 13:04:39 CST 2021, time=2021-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970921, encodeId=a9bd9e092125, content=学习了٩(๑^o^๑)۶, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210604/089492f938c14d9388763519ccaa8830/9e41eaeb5362468d9c0ced660e8eda2a.jpg, createdBy=65941381866, createdName=happycooler, createdTime=Fri Jun 04 16:57:01 CST 2021, time=2021-06-04, status=1, ipAttribution=)]
    2021-08-12 ms4000000843810017

    学习了

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1051769, encodeId=ec3e1051e692f, content=值得学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c905475903, createdName=湘雅科教, createdTime=Thu Sep 16 00:16:30 CST 2021, time=2021-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007288, encodeId=fb65100e28816, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210813/759caf56c3484eacbfe31dd805343725/ef96d9acb98241bcbae5f1d696677e20.jpg, createdBy=2d545571357, createdName=ms4000000843810017, createdTime=Thu Aug 12 15:01:59 CST 2021, time=2021-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=973439, encodeId=0ce99e343951, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210615/49ed71c9ebbe4efab84b5b13e4ffdc4d/f76222ffae3944948a4c06e684458801.jpg, createdBy=89155326955, createdName=148bedacm12暂无昵称, createdTime=Mon Jun 14 13:06:31 CST 2021, time=2021-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=971820, encodeId=feb39e182008, content=学习啦, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5c8e5452710, createdName=ms4000001114161496, createdTime=Tue Jun 08 13:04:39 CST 2021, time=2021-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970921, encodeId=a9bd9e092125, content=学习了٩(๑^o^๑)۶, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210604/089492f938c14d9388763519ccaa8830/9e41eaeb5362468d9c0ced660e8eda2a.jpg, createdBy=65941381866, createdName=happycooler, createdTime=Fri Jun 04 16:57:01 CST 2021, time=2021-06-04, status=1, ipAttribution=)]
    2021-06-14 148bedacm12暂无昵称

    学习

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1051769, encodeId=ec3e1051e692f, content=值得学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c905475903, createdName=湘雅科教, createdTime=Thu Sep 16 00:16:30 CST 2021, time=2021-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007288, encodeId=fb65100e28816, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210813/759caf56c3484eacbfe31dd805343725/ef96d9acb98241bcbae5f1d696677e20.jpg, createdBy=2d545571357, createdName=ms4000000843810017, createdTime=Thu Aug 12 15:01:59 CST 2021, time=2021-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=973439, encodeId=0ce99e343951, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210615/49ed71c9ebbe4efab84b5b13e4ffdc4d/f76222ffae3944948a4c06e684458801.jpg, createdBy=89155326955, createdName=148bedacm12暂无昵称, createdTime=Mon Jun 14 13:06:31 CST 2021, time=2021-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=971820, encodeId=feb39e182008, content=学习啦, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5c8e5452710, createdName=ms4000001114161496, createdTime=Tue Jun 08 13:04:39 CST 2021, time=2021-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970921, encodeId=a9bd9e092125, content=学习了٩(๑^o^๑)۶, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210604/089492f938c14d9388763519ccaa8830/9e41eaeb5362468d9c0ced660e8eda2a.jpg, createdBy=65941381866, createdName=happycooler, createdTime=Fri Jun 04 16:57:01 CST 2021, time=2021-06-04, status=1, ipAttribution=)]
    2021-06-08 ms4000001114161496

    学习啦

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1051769, encodeId=ec3e1051e692f, content=值得学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c905475903, createdName=湘雅科教, createdTime=Thu Sep 16 00:16:30 CST 2021, time=2021-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007288, encodeId=fb65100e28816, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210813/759caf56c3484eacbfe31dd805343725/ef96d9acb98241bcbae5f1d696677e20.jpg, createdBy=2d545571357, createdName=ms4000000843810017, createdTime=Thu Aug 12 15:01:59 CST 2021, time=2021-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=973439, encodeId=0ce99e343951, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210615/49ed71c9ebbe4efab84b5b13e4ffdc4d/f76222ffae3944948a4c06e684458801.jpg, createdBy=89155326955, createdName=148bedacm12暂无昵称, createdTime=Mon Jun 14 13:06:31 CST 2021, time=2021-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=971820, encodeId=feb39e182008, content=学习啦, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5c8e5452710, createdName=ms4000001114161496, createdTime=Tue Jun 08 13:04:39 CST 2021, time=2021-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970921, encodeId=a9bd9e092125, content=学习了٩(๑^o^๑)۶, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210604/089492f938c14d9388763519ccaa8830/9e41eaeb5362468d9c0ced660e8eda2a.jpg, createdBy=65941381866, createdName=happycooler, createdTime=Fri Jun 04 16:57:01 CST 2021, time=2021-06-04, status=1, ipAttribution=)]
    2021-06-04 happycooler

    学习了٩(๑^o^๑)۶

    0

拓展阅读

【协和医学杂志】《晚期癌症患者呼吸困难处理:美国临床肿瘤学会指南》解读

本文对该指南重点内容进行详细解读,并结合中国国情进行分析,以期为指导中国临床实践提供参考。

改良呼吸困难分级

改良呼吸困难分级

改良英国MRC呼吸困难分级量表(mMRC)

改良英国MRC呼吸困难分级量表(mMRC)

湘雅最新研究:俯身呼吸困难心衰,预后更差!

研究显示,存在俯身呼吸困难心衰患者的心衰再入院风险增加85%,心原性死亡风险增加50%。

趴着可救命!新冠病毒感染者出现呼吸困难宜采用俯卧位通气

虽然俯卧位通气可有效改善ARDS患者的氧合情况,但此法并非人人适用

韩国踩踏事故伤亡发生在18平方米空间内,300多人叠了近7层

据韩国《中央日报》10月30日晚最新消息,截至当地时间30日晚9时,梨泰院踩踏事故遇难者已致154人死亡 (含26名外国人),其中,男性56人,女性98人。

2020 ESMO临床实践指南:癌症患者呼吸困难的管理

欧洲肿瘤内科学会(ESMO,European Society for Medical Oncology) · 2020-12-05